Journal of Cutaneous Pathology· 2026Q2
New Annular, Indurated Plaques During Mogamulizumab Therapy in Cutaneous T‐Cell Lymphoma: A Clinicopathologic Pitfall
- 0citations
- Q2SCImago
- 2026year
Short summary
Annular, indurated plaques appearing during mogamulizumab therapy for CTCL can mimic disease progression or drug reactions but histopathology in two darker-skinned patients revealed persistent mycosis fungoides.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Dermatology
DermatologyMedicine